Pulmonary administration of perfluorodecaline-gentamicin and perfluorodecaline-vancomycin emulsions

American Journal of Respiratory and Critical Care Medicine

Volumn 164, Issue 9, 2001, Pages 1595-1600

  Franz, Axel R ^a   Röhlke, Wolfgang ^b   Franke, Ralf P ^b   Ebsen, Michael ^b   Pohlandt, Frank ^b   Hummler, Helmut D ^b  

^a Division of Neonatology and Pediatric Critical Care   (Germany)

^b NONE

Author keywords

Antibiotics; Bacterial pneumonia; Drug administration routes; Fluorocarbons; Gentamicin; Mechanical ventilation; Topical administration; Vancomycin

Indexed keywords

GENTAMICIN; PERFLUORODECALIN; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG ELIMINATION; GAS EXCHANGE; INTRAPULMONARY DRUG ADMINISTRATION; LIQUID VENTILATION; LUNG HEMODYNAMICS; LUNG MECHANICS; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0035508450     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.164.9.2104088     Document Type: Article

References (37)

1. Bacterial pneumonias
2. Intratracheal perfluorocarbon administration as an aid in the ventilatory management of respiratory distress syndrome
3. Partial liquid ventilation in premature lambs with respiratory distress syndrome: Efficacy and compatibility with exogenous surfactant
4. Liquid assisted ventilation: An alternative ventilatory strategy for acute meconium aspiration injury
5. Liquid ventilation: Effects on pulmonary function in distressed meconium-stained lambs
6. Liquid ventilation in adults, children, and full-term neonates
7. Partial liquid ventilation with perflubron in premature infants with severe respiratory distress syndrome
8. Initial experience with partial liquid ventilation in adult patients with the acute respiratory distress syndrome
9. Initial experience with partial liquid ventilation in pediatric patients with the acute respiratory distress syndrome
10. Partial liquid ventilation in adult patients with ARDS: A multicenter phase I-II trial
11. Partial liquid ventilation with perfluorocarbon in the treatment of rats with lethal pneumococcal pneumonia
12. Management of pulmonary disease in patients with cystic fibrosis
13. Evidence for using nebulised antibiotics in cystic fibrosis
14. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis
15. Quantitative deposition of aerosolized gentamicin in cystic fibrosis
16. The quantitative distribution of nebulized antibiotic in the lung in cystic fibrosis
17. Pharmacokinetics of gentamicin administered intratracheally or as an inhalation aerosol to guinea pigs
18. Pulmonary administration of vasoactive substances by perfluorochemical ventilation
19. Combining partial liquid ventilation with nitric oxide to improve gas exchange in acute lung injury
20. Treatment of pulmonary hypertension and hypoxia due to oleic acid induced lung injury with intratracheal prostaglandin E1 during partial liquid ventilation
21. Halothane administration during liquid ventilation
22. A comparison of intratracheal and intravenous administration of gentamicin during liquid ventilation
23. Pulmonary administration of gentamicin during liquid ventilation in a newborn lamb lung injury model
24. Intra-tracheal delivery strategy of gentamicin with partial liquid ventilation
25. In vivo lung lavage as an experimental model of the respiratory distress syndrome
26. Exogenous surfactant and partial liquid ventilation: Physiologic and pathologic effects
27. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients
28. Nosocomial infections: Prospective survey of incidence in five French intensive care units
29. Hospital-acquired pneumonia: Epidemiology, etiology, and treatment
30. Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum
31. Penetration of antibiotics into respiratory secretions
32. The penetration of aminoglycosides into the alveolar lining fluid of rats. The effect of airway inflammation
33. Pulmonary disposition of vancomycin in critically ill patients
34. Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients
35. Pharmacokinetics of vancomycin in adult cystic fibrosis patients
36. Clinical pharmacokinetics of vancomycin
37. Perfluorochemical rescue after surfactant treatment: Effect of perflubron dose and ventilatory frequency